Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Buee

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Advances in Experimental Medicine and Biology|February 26, 2020
Dementia Therapy Targeting TauLuc Buee
Advances in Experimental Medicine and Biology|February 26, 2020
Emerging Connections Between Tau and Nucleic AcidsMarie-Christine Galas, Eliette Bonnefoy, Luc Buee, et al.
Advances in Experimental Medicine and Biology|February 26, 2020
Tau, Diabetes and InsulinMaud Gratuze, Aurélie Joly-Amado, Luc Buee, et al.
Frontiers in Molecular Neuroscience|January 11, 2014
Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathyMarie-Laure Caillet-Boudin, Francisco-Jose Fernandez-Gomez, Hélène Tran, et al.
Neurobiology of Aging|June 11, 2014
Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletionTariq Ahmed, Ann Van der Jeugd, David Blum, et al.
Current Alzheimer Research|January 26, 2012
Hippocampal BDNF expression in a tau transgenic mouse modelSylvie Burnouf, Karim Belarbi, Laetitia Troquier, et al.
Current Alzheimer Research|October 28, 2015
Aβ1-40 and Aβ1-42 Plasmatic Levels In Stroke: Influence of Pre-Existing Cognitive Status and Stroke CharacteristicsSolene Moulin, Didier Leys, Susanna Schraen-Maschke, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 24, 2024
Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairmentSylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, et al.
International Journal of Molecular Sciences|June 24, 2022
Microtube Array Membrane Encapsulated Cell Therapy: A Novel Platform Technology Solution for Treatment of Alzheimer's DiseaseShu-Mei Chen, Tsung-Chin Hsu, Chee-Ho Chew, et al.
Current Alzheimer Research|January 26, 2012
Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approachLaetitia Troquier, Raphaelle Caillierez, Sylvie Burnouf, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|February 26, 2020
Dementia Therapy Targeting TauLuc Buee
Advances in Experimental Medicine and Biology|February 26, 2020
Emerging Connections Between Tau and Nucleic AcidsMarie-Christine Galas, Eliette Bonnefoy, Luc Buee, et al.
Advances in Experimental Medicine and Biology|February 26, 2020
Tau, Diabetes and InsulinMaud Gratuze, Aurélie Joly-Amado, Luc Buee, et al.
Frontiers in Molecular Neuroscience|January 11, 2014
Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathyMarie-Laure Caillet-Boudin, Francisco-Jose Fernandez-Gomez, Hélène Tran, et al.
Neurobiology of Aging|June 11, 2014
Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletionTariq Ahmed, Ann Van der Jeugd, David Blum, et al.
Current Alzheimer Research|January 26, 2012
Hippocampal BDNF expression in a tau transgenic mouse modelSylvie Burnouf, Karim Belarbi, Laetitia Troquier, et al.
Current Alzheimer Research|October 28, 2015
Aβ1-40 and Aβ1-42 Plasmatic Levels In Stroke: Influence of Pre-Existing Cognitive Status and Stroke CharacteristicsSolene Moulin, Didier Leys, Susanna Schraen-Maschke, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 24, 2024
Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairmentSylvain Lehmann, Susanna Schraen-Maschke, Jean-Sébastien Vidal, et al.
International Journal of Molecular Sciences|June 24, 2022
Microtube Array Membrane Encapsulated Cell Therapy: A Novel Platform Technology Solution for Treatment of Alzheimer's DiseaseShu-Mei Chen, Tsung-Chin Hsu, Chee-Ho Chew, et al.
Current Alzheimer Research|January 26, 2012
Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approachLaetitia Troquier, Raphaelle Caillierez, Sylvie Burnouf, et al.
Pageof 3